Epidemiology of gout

Rheumatic Disease Clinics of North America

Volumn 40, Issue 2, 2014, Pages 155-175

  Roddy, Edward ^a   Choi, Hyon K ^b  

^a KEELE UNIVERSITY   (United Kingdom)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epidemiology; Etiology; Gout; Hyperuricemia; Incidence; Prevalence

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; ANGIOTENSIN RECEPTOR ANTAGONIST; ASCORBIC ACID; BENDROFLUMETHIAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FRUCTOSE; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; LOSARTAN; PLACEBO; PURINE; URATE; URIC ACID;

ALCOHOL CONSUMPTION; CHERRY; COFFEE; DIABETES MELLITUS; DIET; DOSE RESPONSE; DRUG MEGADOSE; GEOGRAPHIC DISTRIBUTION; GOUT; HUMAN; HYPERTENSION; HYPERURICEMIA; INCIDENCE; KIDNEY DISEASE; LOW DRUG DOSE; METABOLIC SYNDROME X; MILK; OBESITY; OSTEOARTHRITIS; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SLEEP DISORDERED BREATHING; SYSTEMATIC REVIEW (TOPIC); UNITED STATES; URIC ACID BLOOD LEVEL; EPIDEMIOLOGY; FEEDING BEHAVIOR; KIDNEY FAILURE, CHRONIC; PROTECTION;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN RECEPTOR ANTAGONISTS; DIURETICS; FOOD HABITS; GOUT; HUMANS; HYPERTENSION; HYPERURICEMIA; INCIDENCE; KIDNEY FAILURE, CHRONIC; METABOLIC SYNDROME X; OBESITY; PREVALENCE; PROTECTIVE FACTORS; RISK FACTORS; UNITED STATES;

EID: 84898601021     PISSN: 0889857X     EISSN: 15583163     Source Type: Journal    
DOI: 10.1016/j.rdc.2014.01.001     Document Type: Review

References (81)

1. Chandratre P., Roddy E., Clarson L., et al. Health-related quality of life in gout: a systematic review. Rheumatology (Oxford) 2013, 52(11):2031-2040.
2. Lawrence R.C., Hochberg M.C., Kelsey J.L., et al. Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States. J Rheumatol 1989, 16:427-441.
3. Lawrence R.C., Helmick C.G., Arnett F.C., et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998, 41:778-799.
4. Lawrence R.C., Felson D.T., Helmick C.G., et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008, 58:26-35.
5. Juraschek S.P., Miller E.R., Gelber A.C. Body mass index, obesity, and prevalent gout in the United States in 1988-1994 and 2007-2010. Arthritis Care Res (Hoboken) 2013, 65:127-132.
6. Zhu Y., Pandya B.J., Choi H.K. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 2011, 63:3136-3141.
7. Wallace K.L., Riedel A.A., Joseph-Ridge N., et al. Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol 2004, 31:1582-1587.
8. Currie W.J. Prevalence and incidence of the diagnosis of gout in Great Britain. Ann Rheum Dis 1979, 38:101-106.
9. Steven M.M. Prevalence of chronic arthritis in four geographical areas of the Scottish Highlands. Ann Rheum Dis 1992, 51:186-194.
10. Harris C.M., Lloyd D.C., Lewis J. The prevalence and prophylaxis of gout in England. J Clin Epidemiol 1995, 48:1153-1158.
11. Mikuls T.R., Farrar J.T., Bilker W.B., et al. Gout epidemiology: results from the UK General Practice Research Database, 1990-1999. Ann Rheum Dis 2005, 64:267-272.
12. Annemans L., Spaepen E., Gaskin M., et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis 2008, 67:960-966.
13. Elliot A.J., Cross K.W., Fleming D.M. Seasonality and trends in the incidence and prevalence of gout in England and Wales 1994-2007. Ann Rheum Dis 2009, 68:1728-1733.
14. Lennane G.A., Rose B.S., Isdale I.C. Gout in the Maori. Ann Rheum Dis 1960, 19:120-125.
15. Prior I.A., Rose B.S. Uric acid, gout and public health in the South Pacific. N Z Med J 1966, 65:295-300.
16. Klemp P., Stansfield S.A., Castle B., et al. Gout is on the increase in New Zealand. Ann Rheum Dis 1997, 56:22-26.
17. Winnard D., Wright C., Jackson G., et al. Gout, diabetes and cardiovascular disease in the Aotearoa New Zealand adult population: co-prevalence and implications for clinical practice. N Z Med J 2012, 126:53-64.
18. Nan H., Qiao Q., Dong Y., et al. The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China. J Rheumatol 2006, 33:1346-1350.
19. Miao Z., Li C., Chen Y., et al. Dietary and lifestyle changes associated with high prevalence of hyperuricaemia and gout in the Shandong coastal cities of Eastern China. J Rheumatol 2008, 35:1859-1864.
20. Roubenoff R., Klag M.J., Mead L.A., et al. Incidence and risk factors for gout in white men. JAMA 1991, 266:3004-3007.
21. Choi H.K., Atkinson K., Karlson E.W., et al. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004, 350:1093-1103.
22. Wallace S.L., Robinson H., Masi A.T., et al. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977, 20:895-900.
23. Bhole V., de Vera M., Rahman M.M., et al. Epidemiology of gout in women: fifty-two-year followup of a prospective cohort. Arthritis Rheum 2010, 62:1069-1076.
24. Arromdee E., Michet C.J., Crowson C.S., et al. Epidemiology of gout: is the incidence rising?. J Rheumatol 2002, 29:2403-2406.
25. Cea Soriano L., Rothenbacher D., Choi H.K., et al. Contemporary epidemiology of gout in the UK general population. Arthritis Res Ther 2011, 13:R39.
26. Campion E.W., Glynn R.J., Delabry L.O. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med 1987, 82:421-426.
27. Trifirò G., Morabito P., Cavagna L. Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study. Ann Rheum Dis 2013, 72:694-700.
28. Lin K.C., Lin H.Y., Chou P. The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study. J Rheumatol 2000, 27:1501-1505.
29. Dalbeth N., Wong S., Gamble G.D., et al. Acute effect of milk on serum urate concentrations: a randomised controlled crossover trial. Ann Rheum Dis 2010, 69:1677-1682.
30. Garrel D.R., Verdy M., Petitclerc C., et al. Milk- and soy-protein ingestion: acute effect on serum uric acid concentration. Am J Clin Nutr 1991, 53:665-669.
31. Dalbeth N., Ames R., Gamble G.D., et al. Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomised controlled trial. Ann Rheum Dis 2012, 71:929-934.
32. Zhang Y., Chen C., Choi H., et al. Purine-rich foods intake and recurrent gout attacks. Ann Rheum Dis 2012, 71:1448-1453.
33. Bruce C.R., Carey A.L., Hawley J.A., et al. Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism. Diabetes 2003, 52:2338-2345.
34. Thirunavukkarasu V., Anuradha C.V. Influence of α-lipoic acid on lipid peroxidation and antioxidant defence system in blood of insulin-resistant rats. Diabetes Obes Metab 2004, 6:200-207.
35. Ter Maaten J.C., Voorburg A., Heine R.J., et al. Renal handling of urate and sodium during acute physiological hyperinsulinaemia in healthy subjects. Clin Sci (Lond) 1997, 92:51-58.
36. Kela U., Vijayvargiya R., Trivedi C.P. Inhibitory effects of methylxanthines on the activity of xanthine oxidase. Life Sci 1980, 27:2109-2119.
37. Choi H.K., Willett W., Curhan G. Coffee consumption and risk of incident gout in men: a prospective study. Arthritis Rheum 2007, 56:2049-2055.
38. Choi H.K., Curhan G. Coffee consumption and risk of incident gout in women: the Nurses' Health Study. Am J Clin Nutr 2010, 92:922-927.
39. Raivio K.O., Becker A., Meyer L.J., et al. Stimulation of human purine synthesis de novo by fructose infusion. Metabolism 1975, 24:861-869.
40. Choi H.K., Curhan G. Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ 2008, 336:309-312.
41. Choi H.K., Willett W., Curhan G. Fructose-rich beverages and risk of gout in women. JAMA 2010, 304:2270-2278.
42. Juraschek S.P., Miller E.R., Gelber A.C. Effect of oral vitamin C supplementation on serum uric acid: a meta-analysis of randomized controlled trials. Arthritis Care Res (Hoboken) 2011, 63:1295-1306.
43. Choi H.K., Gao X., Curhan G. Vitamin C intake and the risk of gout in men: a prospective study. Arch Intern Med 2009, 169:502-507.
44. Zhang Y., Neogi T., Chen C., et al. Cherry consumption and decreased risk of recurrent gout attacks. Arthritis Rheum 2012, 64:4004-4011.
45. Fam A.G. Gout, diet, and the insulin resistance syndrome. J Rheumatol 2002, 29:1350-1355.
46. Mcadams-Demarco M.A., Maynard J.W., Baer A.N., et al. Hypertension and the risk of incident gout in a population-based study: the atherosclerosis risk in communities cohort. J Clin Hypertens (Greenwich) 2012, 14:675-679.
47. Choi H.K., Atkinson K., Karlson E.W., et al. Alcohol intake and risk of incident gout in men: a prospective study. Lancet 2004, 363:1277-1281.
48. Zhang Y., Woods R., Chaisson C.E., et al. Alcohol consumption as a trigger of recurrent gout attacks. Am J Med 2006, 119:800-808.
49. Choi H.K., Ford E.S., Li C., et al. Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2007, 57:109-115.
50. Choi H.K., Atkinson K., Karlson E.W., et al. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health follow-up study. Arch Intern Med 2005, 165:742-748.
51. Maynard J.W., Mcadams Demarco M.A., Baer A.N., et al. Incident gout in women and association with obesity in the Atherosclerosis Risk in Communities (ARIC) study. Am J Med 2012, 125:717.e9-717.e17.
52. Rothenbacher D., Primatesta P., Ferreira A., et al. Frequency and risk factors of gout flares in a large population-based cohort of incident gout. Rheumatology (Oxford) 2011, 50:973-981.
53. Rodríguez G., Soriano L.C., Choi H.K. Impact of diabetes against the future risk of developing gout. Ann Rheum Dis 2010, 69:2090-2094.
54. Herman J.B., Goldbourt U. Uric acid and diabetes: observations in a population study. Lancet 1982, 2:240-243.
55. Choi H.K., Ford E.S. Haemoglobin A1c, fasting glucose, serum C-peptide and insulin resistance in relation to serum uric acid levels-the Third National Health and Nutrition Examination Survey. Rheumatology (Oxford) 2008, 47:713-717.
56. Cook D.G., Shaper A.G., Thelle D.S., et al. Serum uric acid, serum glucose and diabetes: relationships in a population study. Postgrad Med J 1986, 62:1001-1006.
57. Parish J.M., Adam T., Facchiano L. Relationship of metabolic syndrome and obstructive sleep apnea. J Clin Sleep Med 2007, 3:467-472.
58. Kono M., Tatsumi K., Saibara T., et al. Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest 2007, 131:1387-1392.
59. Ruiz García A., Sánchez Armengol A., Luque Crespo E., et al. Blood uric acid levels in patients with sleep-disordered breathing. Arch Bronconeumol 2006, 42:492-500.
60. Glantzounis G.K., Tsimoyiannis E.C., Kappas A.M., et al. Uric acid and oxidative stress. Curr Pharm Des 2005, 11:4145-4151.
61. Hasday J.D., Grum C.M. Nocturnal increase of urinary uric acid: creatinine ratio. A biochemical correlate of sleep-associated hypoxemia. Am Rev Respir Dis 1987, 135:534-538.
62. Roddy E., Muller S., Hayward R., et al. The association of gout with sleep disorders: a cross-sectional study in primary care. BMC Musculoskelet Disord 2013, 14:119.
63. Choi H.K., Mount D.B., Reginato A.M., et al. Pathogenesis of gout. Ann Intern Med 2005, 143:499-516.
64. Hueskes B.A., Roovers E.A., Mantel-Teeuwisse A.K., et al. Use of diuretics and the risk of gouty arthritis: a systematic review. Semin Arthritis Rheum 2012, 41:879-889.
65. Gurwitz J.H., Kalish S.C., Bohn R.L., et al. Thiazide diuretics and the initiation of anti-gout therapy. J Clin Epidemiol 1997, 50:953-959.
66. Hanly J.G., Skedgel C., Sketris I., et al. Gout in the elderly - a population health study. J Rheumatol 2009, 36:822-830.
67. Hunter D.J., York M., Chaisson C.E., et al. Recent diuretic use and the risk of recurrent gout attacks: the online case-crossover gout study. J Rheumatol 2006, 33:1341-1345.
68. Stamp L., Ha L., Searle M., et al. Gout in renal transplant recipients. Nephrology (Carlton) 2006, 11:367-371.
69. Suppiah R., Dissanayake A., Dalbeth N. High prevalence of gout in patients with Type 2 diabetes: male sex, renal impairment, and diuretic use are major risk factors. N Z Med J 2008, 121:43-50.
70. Choi H.K., Soriano L.C., Zhang Y., et al. Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study. BMJ 2012, 344:d8190.
71. Yü T.F., Gutman A.B. Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man. J Clin Invest 1959, 38:1298-1315.
72. Zhang Y., Neogi T., Chen C., et al. Low-dose aspirin use and recurrent gout attacks. Ann Rheum Dis 2014, 73(2):385-390.
73. Reyes A.J. Cardiovascular drugs and serum uric acid. Cardiovasc Drugs Ther 2003, 17:397-414.
74. Berger L., Yü T.F. Renal function in gout. IV. An analysis of 524 gouty subjects including long-term follow-up studies. Am J Med 1975, 59:605-613.
75. Fessel W.J. Renal outcomes of gout and hyperuricemia. Am J Med 1979, 67:74-82.
76. Yü T.F., Berger L. Impaired renal function in gout. Its association with hypertensive vascular disease and intrinsic renal disease. Am J Med 1982, 72:95-100.
77. Roddy E., Doherty M. Gout and osteoarthritis: a pathogenetic link?. Joint Bone Spine 2012, 79:425-427.
78. Roddy E. Revisiting the pathogenesis of podagra: why does gout target the foot?. J Foot Ankle Res 2011, 4:13.
79. Kawenoki-Minc E., Eyman E., Leo W., et al. Osteoarthrosis and spondylosis in gouty patients. Analysis of 262 cases of gout. Reumatologia 1974, 12:267-277.
80. Roddy E., Zhang W., Doherty M. Are joints affected by gout also affected by osteoarthritis?. Ann Rheum Dis 2007, 66:1374-1377.
81. Roddy E., Zhang W., Doherty M. Gout and nodal osteoarthritis: a case-control study. Rheumatology 2008, 7:732-733.